Picture of ContextVision AB logo

CONTX ContextVision AB News Story

0.000.00%
no flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapFalling Star

Brief: ContextVision awarded research grant to develop new technology

July 9 (Reuters) - ContextVision AB  COVI.OL : 
    * Awarded research grant to develop new technology 
    * Together with its academic partner been awarded a research 
grant of 683,000 euros ($758,471.50) for a research program 
aimed at developing new imaging technology within prostate 
cancer and digital pathology 
    * Expanded technology platform will position company in 
markets with total sales of 1,500 million Swedish crowns  
($177.68 million) by 2018 
 
Source text for Eikon:  ID:nHUG6CXqPK  
     
Further company coverage:  COVI.OL  
 
($1 = 8.4423 Swedish crowns) 
 
($1 = 0.9005 euros) 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))

Recent news on ContextVision AB

See all news